Feature of fabaceae family
Fabaceae family characteristics features botany
| Subfamily | Symmetry | Example |
|---|---|---|
| Faboideae (Papilionoideae) | Zygomorphic (bilateral) | Pea, Bean, Lathyrus |
| Caesalpinioideae | Slightly zygomorphic | Cassia, Bauhinia |
| Mimosoideae (now tribe Mimoseae) | Actinomorphic (radial) | Mimosa, Acacia |
Metrorrhagia
metrorrhagia causes diagnosis management clinical features
metrorrhagia definition causes PALM-COEIN classification treatment gynecology
https://www.merckmanuals.com/professional/gynecology-and-obs…
Important Note on Terminology: FIGO (International Federation of Gynecology and Obstetrics) no longer recommends the term "metrorrhagia." Since 2011, it has been replaced by "Intermenstrual Bleeding (IMB)" under the modern PALM-COEIN classification system for Abnormal Uterine Bleeding (AUB). The older terms (menorrhagia, metrorrhagia, menometrorrhagia, DUB) are considered obsolete.
| Old Term | Modern Term | Description |
|---|---|---|
| Metrorrhagia | Intermenstrual bleeding (IMB) | Bleeding between periods, at irregular intervals |
| Menorrhagia | Heavy menstrual bleeding (HMB) | Excessive bleeding during periods (>80 mL) |
| Menometrorrhagia | AUB - heavy + irregular | Heavy, prolonged AND irregular bleeding |
| Polymenorrhea | Frequent menstruation | Cycle interval < 24 days |
| Oligomenorrhea | Infrequent menstruation | Cycle interval > 38 days |
| Cause | Notes |
|---|---|
| Polyp (P) - Endometrial or cervical polyp | Most common structural cause of IMB; hyperplastic overgrowth of endometrial tissue |
| Adenomyosis (A) | Endometrial glands within myometrium; boggy uterus |
| Leiomyoma (L) - Uterine fibroids | Especially submucosal fibroids distort the endometrial cavity |
| Malignancy & Hyperplasia (M) | Endometrial carcinoma, cervical carcinoma - must be excluded in all cases |
| Cause | Notes |
|---|---|
| Coagulopathy (C) | Von Willebrand disease (most common), thrombocytopenia, liver disease |
| Ovulatory dysfunction (O) | PCOS, hypothyroidism, hyperprolactinemia, perimenopause, extreme weight changes, stress |
| Endometrial (E) | Primary endometrial dysfunction in a structurally normal uterus (diagnosis of exclusion) |
| Iatrogenic (I) | OCP use (breakthrough bleeding), IUDs, anticoagulants, antipsychotics (via hyperprolactinemia) |
| Not yet classified (N) | Caesarean scar defect, uterine arteriovenous malformations (AVM) |
| Investigation | Purpose |
|---|---|
| Urine/serum βhCG | Exclude pregnancy (first priority) |
| CBC + ferritin | Assess for anemia |
| Coagulation screen | Especially if bleeding since menarche |
| TFTs (TSH) | Thyroid disease |
| Prolactin | Hyperprolactinemia |
| Androgens (testosterone, DHEAS) | PCOS |
| Cervical smear + STI swabs | Infection, cervical pathology |
| Transvaginal ultrasound (TVUS) | First-line imaging - polyps, fibroids, endometrial thickness |
| Hysteroscopy + endometrial biopsy | Gold standard for intracavitary pathology; mandatory if >45 yrs or risk factors for endometrial cancer |
| Saline infusion sonography (SIS) | Better delineation of intracavitary lesions |